Skip to main content
Log in

T-cell Immunoglobulin and Mucin Domain 3 in Circulating Monocytes as a Novel Biomarker for Coronary Artery Disease

  • Original Article
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

The diagnostic role of T-cell immunoglobulin and mucin domain 3 (Tim-3) expression levels in circulating monocytes in coronary artery disease (CAD) remains to be determined. Here, we enrolled of 265 patients and isolated circulating monocytes from the blood of all participants. We found that the Tim-3 expression levels in monocytes were lower in CAD patients than in the control group. Spearman correlation analysis verified that the Tim-3 levels in monocytes were negatively correlated with the Gensini score and the number of coronary vessels. Multivariate logistic regression analysis showed that the Tim-3 levels in circulating monocytes were negatively correlated with CAD, severe CAD, and three-vessel CAD. The ROC curve showed that Tim-3 possessed high diagnostic value for CAD, severe CAD, and three-vessel CAD, with CAD prediction being the most significant of these values. In conclusion, Tim-3 in circulating monocytes is a novel biomarker for CAD.

Graphical Abstract

T-cell immunoglobulin and mucin domain 3 (Tim-3) in circulating monocytes as a novel biomarker for coronary artery disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Data is available upon request.

Abbreviations

Tim-3:

 T-cell immunoglobulin and mucin domain 3

CAD:

Coronary artery disease

AS:

Atherosclerosis

WBCC:

White blood cell count

NEUT%:

Neutrophilic granulocyte percentage

LYMP%:

Lymphocyte proportion

MONO%:

Monocyte percentage

Cr:

Creatinine

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

LDH:

Lactic dehydrogenase

TC:

Total cholesterol

TG:

Triglyceride

LDL-C:

Low-density lipoprotein-cholesterol

HDL-C:

High-density lipoprotein-cholesterol

Fg:

Fibrinogen

FDP:

Fibrinogen degradation products

DD:

D-dimer

AT-III:

Antithrombin III

APTT:

Activated partial thromboplastin time

qPCR:

Quantitative real-time PCR

GAPDH:

Glyceraldehyde 3-phosphate dehydrogenase

ROC:

Receiver operating characteristic

AUC:

Area under the curve

BMI:

Body mass index

References

  1. Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res. 2019;124(2):315–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nakanishi Y, Kang S, Kumanogoh A. Axon guidance molecules in immunometabolic diseases. Inflamm Regen. 2022;42(1):5.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American heart association. Circulation. 2022;145(8):e153–639.

    Article  PubMed  Google Scholar 

  4. Nayor M, Brown KJ, Vasan RS. The molecular basis of predicting atherosclerotic cardiovascular disease risk. Circ Res. 2021;128(2):287–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhao L, Cheng S, Fan L, Zhang B, Xu S. TIM-3: An update on immunotherapy. Int Immunopharmacol. 2021;99:107933.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang Y, Ma CJ, Wang JM, et al. Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes. J Leukoc Biol. 2012;91(2):189–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ocaña-Guzman R, Torre-Bouscoulet L, Sada-Ovalle I. TIM-3 regulates distinct functions in macrophages. Front Immunol. 2016;7:229.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wang W, Xu Z, Zhang J, et al. Tim-3 is a potential regulator that inhibits monocyte inflammation in response to intermittent hypoxia in children with obstructive sleep apnea syndrome. Clin Immunol. 2021;222:108641.

    Article  CAS  PubMed  Google Scholar 

  9. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.

    Article  CAS  PubMed  Google Scholar 

  10. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(3):e18–114.

    PubMed  Google Scholar 

  11. Alan B, Akpolat V, Aktan A, Alan S. Relationship between osteopenic syndrome and severity of coronary artery disease detected with coronary angiography and Gensini score in men. Clin Interv Aging. 2016;11:377–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Qiu G, Zheng G, Ge M, Huang L, Tong H, Chen P, et al. Adipose-derived mesenchymal stem cells modulate CD14(++)CD16(+) expression on monocytes from sepsis patients in vitro via prostaglandin E2. Stem Cell Res Ther. 2017;8(1):97. https://doi.org/10.1186/s13287-017-0546-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Karimi Z, Oskouie AA, Rezaei F, Ajaminejad F, Marashi SM, Azad TM. The effect of influenza virus on the metabolism of peripheral blood mononuclear cells with a metabolomics approach. J Med Virol. 2022;94(9):4383–92.

    Article  CAS  PubMed  Google Scholar 

  14. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–22. https://doi.org/10.1373/clinchem.2008.112797.

    Article  CAS  PubMed  Google Scholar 

  15. Arocho A, Chen B, Ladanyi M, Pan Q. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol. 2006;15(1):56–61.

    Article  CAS  PubMed  Google Scholar 

  16. Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812–23.

    Article  CAS  PubMed  Google Scholar 

  17. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Morange PE, Bickel C, Nicaud V, et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol. 2006;26(12):2793–9.

    Article  CAS  PubMed  Google Scholar 

  19. Tang X, Zhang Z, Fang M, et al. Transferrin plays a central role in coagulation balance by interacting with clotting factors. Cell Res. 2020;30(2):119–32.

    Article  CAS  PubMed  Google Scholar 

  20. Zhang Y, Ma CJ, Wang JM, et al. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection. PLoS One. 2011;6(5):e19664.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Du X, Wu Z, Xu Y, et al. Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cell Mol Immunol. 2019;16(11):878–86.

    Article  CAS  PubMed  Google Scholar 

  22. Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8).

  23. Shao C, Wang J, Tian J, Tang YD. Coronary artery disease: from mechanism to clinical practice. Adv Exp Med Biol. 2020;1177:1–36.

    Article  CAS  PubMed  Google Scholar 

  24. Sechtem U, Brown D, Godo S, Lanza GA, Shimokawa H, Sidik N. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease). Cardiovasc Res. 2020;116(4):771–86. https://doi.org/10.1093/cvr/cvaa005.

    Article  CAS  PubMed  Google Scholar 

  25. Waheed N, Elias-Smale S, Malas W, Maas AH, Sedlak TL, Tremmel J, et al. Sex differences in non-obstructive coronary artery disease. Cardiovasc Res. 2020;116(4):829–40. https://doi.org/10.1093/cvr/cvaa001.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Health Commission of Jiangsu Province (grant number ZD2022016) and the Science and Technology Office of Nanjing Medical University (grant number NMU20210039).

Author information

Authors and Affiliations

Authors

Contributions

M.H were responsible for designing the experiments. FPX, ZQJ, and L.W. performed the experiments. M.L., XXC and Z.G. collected data. All authors contributed to manuscript preparation and revision.

Corresponding author

Correspondence to Mei Hong.

Ethics declarations

Ethics Approval and Consent to Participate

The study was approved by the Ethics Committee of the Second Affiliated Hospital of Nanjing Medical University (approval no. 2022-KY-123–01). All patients signed a written informed consent before participating in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Associate Editor Craig M. Stolen oversaw the review of this article.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 26 KB)

12265_2023_10466_MOESM2_ESM.tif

Supplementary file2 Fig. S1. Correlation analysis of Tim-3 expression in circulating monocytes. a Association between Tim-3 expression and TG. b Association between Tim-3 expression and TC. c Association between Tim-3 expression and LDL-C. D Association between Tim-3 expression and Fg. e Association between Tim-3 expression and DD. f Association between Tim-3 expression and APTT. g Association between Tim-3 expression and PT. h Association between Tim-3 expression and INR. i Association between Tim-3 expression and Gensini score. TC: Total cholesterol; TG: Triglyceride; LDL-C: Low-density lipoprotein-cholesterol; Fg: Fibrinogen; DD: D-dimer; APTT: Activated partial thromboplastin time; PT: Prothrombin time; INR: International normalized ratio (TIF 8717 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, F., Jia, Z., Wang, L. et al. T-cell Immunoglobulin and Mucin Domain 3 in Circulating Monocytes as a Novel Biomarker for Coronary Artery Disease. J. of Cardiovasc. Trans. Res. (2023). https://doi.org/10.1007/s12265-023-10466-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12265-023-10466-7

Keywords

Navigation